Cargando…
Mifepristone inhibits IGF-1 signaling pathway in the treatment of uterine leiomyomas
PURPOSE: To investigate the role of IGF-1 signaling pathway in the treatment of uterine leiomyomas with mifepristone. PATIENTS AND METHODS: From October 2015 to December 2018, 50 patients with uterine leiomyoma were included in this study. Overexpression or siRNA of IGF-1 in primary human uterine le...
Autores principales: | Shen, Qi, Zou, Shuangwei, Sheng, Bo, Zhao, Menghuang, Sun, Lu-Zhe, Zhu, Xueqiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731989/ https://www.ncbi.nlm.nih.gov/pubmed/31564832 http://dx.doi.org/10.2147/DDDT.S212157 |
Ejemplares similares
-
The use of mifepristone in abortion associated with an increased risk of uterine leiomyomas
por: Shen, Qi, et al.
Publicado: (2017) -
A Five-Genes-Based Prognostic Signature for Cervical Cancer Overall Survival Prediction
por: Zhao, Menghuang, et al.
Publicado: (2020) -
The prognostic values of signal transducers activators of transcription family in ovarian cancer
por: Li, Saisai, et al.
Publicado: (2017) -
The Effects of Guizhi Fuling Capsule Drug Serum on Uterine Leiomyoma Cells and Its Mechanism
por: Shen, Qi, et al.
Publicado: (2016) -
Long-term use of ultra-low-dose mifepristone for uterine leiomyoma control and safety discussion: A case report
por: Zhou, Guangdi, et al.
Publicado: (2022)